NEW YORK, Oct. 28, 2014 /PRNewswire/ -- Levi &
Korsinsky, LLP is investigating Northwest Biotherapeutics, Inc.
("Northwest Bio" or the "Company") (NasdaqCM: NWBO) in connection
with possible breaches of federal securities laws. The
investigation regards concerns that the Company made misleading
statements regarding its clinical trial for DC-Vax Direct, its
experimental cancer vaccine.
To get more information, click here:
http://zlk.9nl.com/northwest-biotherapeutics-nwbo. There is
no cost or obligation to you.
On June 19, 2014, an article
featured on TheStreet.com alleged that the MD Anderson Cancer
Center had "issued a stern rebuke to Northwest Biotherapeutics for
making promotional, unjustified claims about results" from the
ongoing drug trial.
If you own common stock in Northwest Bio and wish to obtain
additional information, please contact Eduard Korsinsky, Esq. either via email at
ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972, or visit
http://zlk.9nl.com/northwest-biotherapeutics-nwbo.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY
10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
SOURCE Levi & Korsinsky, LLP